Titelia

Holdings of Virtus KAR Health Sciences Fund

Virtus Investment Trust · 24 declared positions · as of Mar 31, 2026

Original filing · Net assets 89.8M $ · Ten largest lines: 56.3 % of the equity sleeve

Sector breakdown

  • Health care 69.4 %
  • Consumer discretionary 4.4 %
  • Unattributed 26.1 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 100.0 %

Shares computed on the equity sleeve.

CountryLinesValueShare
US2489M $100.00 %

Positions

CompanySharesValueWeight
Eli Lilly & Co 12,98211.9M $13.30 %
McKesson Corp 5,7815M $5.57 %
Vertex Pharmaceuticals Inc 10,2364.6M $5.09 %
AbbVie Inc 21,0004.6M $5.09 %
Merck & Co Inc 37,6944.5M $5.05 %
Intuitive Surgical Inc 9,3474.3M $4.80 %
West Pharmaceutical Services Inc 15,7614M $4.40 %
IDEXX Laboratories Inc 6,8563.9M $4.29 %
Mettler-Toledo International Inc 2,9903.8M $4.20 %
Cooper Cos Inc/The 50,7833.6M $4.05 %
Amgen Inc 10,1793.6M $3.99 %
Regeneron Pharmaceuticals, Inc. 4,4443.4M $3.83 %
Thermo Fisher Scientific Inc 6,9723.4M $3.82 %
Danaher Corp 16,9203.2M $3.57 %
HealthEquity Inc 36,7773.1M $3.42 %
UnitedHealth Group Inc 10,7062.9M $3.23 %
Align Technology Inc 16,3512.8M $3.12 %
Dexcom Inc 43,2902.7M $3.03 %
Lumexa Imaging Holdings Inc 305,5772.6M $2.93 %
US Physical Therapy Inc 32,0202.4M $2.67 %
Insulet Corp 11,3062.4M $2.64 %
STERIS PLC 10,5512.3M $2.60 %
Medline Inc 45,5532M $2.26 %
Prestige Consumer Healthcare Inc 33,4542M $2.21 %